Internal Medicine, Hematology & Oncology · Carmichael, CA
NPI
1114993813
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6555 Coyle Ave, Suite 301
Carmichael, CA, 95608
Phone (916) 961-0258
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
267,956 services
Medicare patients, 2024
813
Average age 72
Drug cost, 2024
$7.2M
1,868 prescriptions
Company payments, 2025
$429
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ram Lalchandani was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 44,370 times for 36 patients. In total Ram Lalchandani billed 267,956 services in 112 codes, and Medicare paid $2.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 44,370 | 36 | $0.27 | $12K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 31,350 | 19 | $0.11 | $3,509 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 19,400 | 19 | $44.69 | $867K |
| J9267 Injection, paclitaxel, 1 mg | Office | 14,898 | 14 | $0.08 | $1,180 |
| J1642 Injection, heparin sodium, (heparin lock flush), per 10 units | Office | 10,700 | 36 | $0.01 | $133 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 6,304 | 54 | $0.07 | $461 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,686 | 51 | $0.09 | $330 |
| J0897 Injection, denosumab, 1 mg | Office | 3,060 | 11 | $20.43 | $63K |
| 85025 Blood Count | Office | 1,660 | 353 | $7.55 | $13K |
| 36415 Venipuncture Blood Collection | Office | 1,140 | 345 | $7.67 | $8,740 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,130 | 16 | $6.35 | $7,180 |
| 99214 Office E&M - Established | Office | 1,073 | 353 | $102.43 | $110K |
| 96367 Intravenous Infusion, Hydration | Office | 719 | 56 | $24.57 | $18K |
| J3480 Injection, potassium chloride, per 2 meq | Office | 705 | 18 | $0.09 | $60.63 |
| 99213 Office E&M - Established | Office | 615 | 420 | $66.10 | $41K |
By year: 2022 $2.2M for 206,776 services; 2023 $1.9M for 196,662 services; 2024 $2.9M for 267,956 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,660 | 353 | $7.55 | $13K |
| 36415 Venipuncture Blood Collection | 1,140 | 345 | $7.67 | $8,740 |
| 80053 Clinical Chemistry | 420 | 105 | $10.35 | $4,347 |
Medicare prescription drug claims, 2024
In 2024, the drug Ram Lalchandani prescribed most often to Medicare patients was Anastrozole, with 162 prescriptions and refills. In total Ram Lalchandani wrote 1,868 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 162 | 360 | 41 | $4,021 |
| Acyclovir Generic | 108 | 131 | 18 | $1,295 |
| Ondansetron Hcl Generic | 86 | 86 | 38 | $13K |
| Potassium Chloride Generic | 84 | 92 | 29 | $646 |
| Eliquis Apixaban | 82 | 91 | 13 | $53K |
| Dexamethasone Generic | 81 | 83 | 34 | $1,002 |
| Revlimid Lenalidomide | 75 | 75 | Under 11 | $1.3M |
| Ondansetron Odt Ondansetron | 61 | 61 | 16 | $921 |
| Lenalidomide Generic | 38 | 38 | Under 11 | $414K |
| Prochlorperazine Maleate Generic | 34 | 34 | 18 | $333 |
| Venclexta Venetoclax | 33 | 33 | Under 11 | $141K |
| Imatinib Mesylate Generic | 33 | 33 | Under 11 | $43K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 33 | 33 | 21 | $330 |
| Letrozole Generic | 33 | 91 | 12 | $1,002 |
| Prednisone Generic | 32 | 33 | Under 11 | $138 |
Brand drugs: 612 claims; generic drugs: 1,256 claims; opioid claims: 92.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ram Lalchandani $429 ($429 in general payments such as food, travel and fees) from 9 companies. The largest payer was Daiichi Sankyo Inc. with $83.4.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 4 | $83.4 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $74.15 |
| Celgene Corporation BMY | 2 | $71.75 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $48.75 |
| Servier Pharmaceuticals LLC | 2 | $40.72 |
| Array Biopharma Inc PFE | 1 | $28.97 |
| Lilly USA, LLC LLY | 1 | $28.02 |
| GlaxoSmithKline, LLC. GSK | 1 | $27.13 |
| Genentech USA, Inc. ROG.SW | 1 | $26.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.